Assessment of Hemodynamic Response in Cardiopulmonary Bypass Graft After Cardiopulmonary Bypass Using Transesophegeal Echocardiography
Phase 4
Completed
- Conditions
- Cardiopulmonary Bypass Graft
- Interventions
- Registration Number
- NCT01616069
- Lead Sponsor
- Federal University of Juiz de Fora
- Brief Summary
This is a double blind randomization study, assessing hemodynamic response in patients who underwent a cardiopulmonary bypass graft (CABG) with cardiopulmonary bypass (CPB) using intraoperative trasnesophageal echocardiography (TEE) to know what inotropic drug will be batter to improve the heart function. Epinephrine, milrinone, dobutamine and levosimendan will be assessment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 81
Inclusion Criteria
- Sinusal ritmus
- EF > 35%
- Elective CABG surgery
Exclusion Criteria
- No accept
- Severe valvular regurgitation or stenoses
- Chest pain
- Cardiogenic shock
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description epinephrine epinephrine and levosimendan Assessment of systolic and diastolic heart function during CABAG with CPB with levosimendan using TEE. levosimendan epinephrine and levosimendan Assessment of systolic and diastolic heart function during CABAG with CPB with epinephrine using TEE.
- Primary Outcome Measures
Name Time Method Systolic and diastolic heart function Two years Assessment the systolic and diastolic heart function
- Secondary Outcome Measures
Name Time Method Mortality after CABAG Two years Assessment mortality after CABAG
Trial Locations
- Locations (1)
National Institute of Cardiology / Ministry of Health
🇧🇷Rio de janeiro, RJ, Brazil